FRESENIUS MEDICAL NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Fresenius Medical Care AG & Co. KGAA To Contact The Firm
NEW YORK, Jan. 26, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Fresenius Medical Care AG & Co. KGAA ("Fresenius Medical" or the "Company") (NYSE: FMS).
The investigation focuses on whether the Company and its executives violated federal securities laws.
Specifically, after market close on January 6, 2017, the Wall Street Journal published an article disclosing that Fresenius Medical's North American subsidiary received a subpoena seeking "information about our interactions" relating to the Company's ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis. On this news, the price of the Company's American Depositary Receipt ("ADR") was negatively affected, causing investors harm.
Request more information now by clicking here: www.faruqilaw.com/FMS . There is no cost or obligation to you.
Take Action
If you invested in Fresenius Medical ADRs and would like to discuss your legal rights, visit www.faruqilaw.com/FMS. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Fresenius Medical's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330
SOURCE Faruqi & Faruqi, LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article